SUNY - Upstate Medical University Div. of Hematology-Oncology
Syracuse, New York, United States
Hematologist in Syracuse, New York
750 E Adams St, Syracuse, NY 13210
About SUNY - Upstate Medical University Div. of Hematology-Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
4
Novartis Pharmaceuticals
3
Clinical Trials at SUNY - Upstate Medical University Div. of Hematology-Oncology
During the past decade, SUNY - Upstate Medical University Div. of Hematology-Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
2007-11-07
2012-04-03
Completed
121
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
2009-01-27
2020-10-27
Completed
317
Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
2009-10-01
2015-05-01
Completed
471
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
2010-03-19
2017-12-31
Completed
1,494
Connect® MM- The Multiple Myeloma Disease Registry
2009-09-01
2024-12-31
Active, not recruiting
3,011
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
2011-03-01
2014-06-01
Completed
564
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly
2014-06-09
2017-07-14
Completed
143
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at SUNY - Upstate Medical University Div. of Hematology-Oncology
According to Clinical.Site data, the most researched conditions in "SUNY - Upstate Medical University Div. of Hematology-Oncology" are
"Multiple Myeloma" (2 trials), "Adenocarcinoma" (1 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Carcinoma" (1 trials) and "Carcinoma, Large Cell" (1 trials). Many other conditions were trialed in "SUNY - Upstate Medical University Div. of Hematology-Oncology" in a lesser frequency.
Clinical Trials Intervention Types at SUNY - Upstate Medical University Div. of Hematology-Oncology
Most popular intervention types in "SUNY - Upstate Medical University Div. of Hematology-Oncology" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (1 trials), "Dovitinib" (1 trials), "Lenalidomide" (1 trials), "Placebo" (1 trials) and "Sorafenib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SUNY - Upstate Medical University Div. of Hematology-Oncology
The vast majority of trials in "SUNY - Upstate Medical University Div. of Hematology-Oncology" are
7 trials for "All" genders.
Clinical Trials Status at SUNY - Upstate Medical University Div. of Hematology-Oncology
Currently, there are NaN active trials in "SUNY - Upstate Medical University Div. of Hematology-Oncology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in SUNY - Upstate Medical University Div. of Hematology-Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SUNY - Upstate Medical University Div. of Hematology-Oncology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".